IGC Pharma, Inc. (IGC)
0.2797
0.00 (0.00%)
USD |
NYAM |
Oct 08, 16:00
0.2854
+0.01
(+2.04%)
After-Hours: 18:00
IGC Pharma Price to Book Value : 4.672 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 4.677 |
| October 06, 2026 | 4.677 |
| October 05, 2026 | 4.710 |
| October 02, 2026 | 4.592 |
| October 01, 2026 | 4.510 |
| September 30, 2026 | 4.491 |
| September 29, 2026 | 4.468 |
| September 28, 2026 | 4.577 |
| September 25, 2026 | 4.717 |
| September 24, 2026 | 4.695 |
| September 23, 2026 | 4.779 |
| September 22, 2026 | 4.727 |
| September 21, 2026 | 4.577 |
| September 18, 2026 | 4.760 |
| September 17, 2026 | 4.450 |
| September 16, 2026 | 4.543 |
| September 15, 2026 | 4.458 |
| September 14, 2026 | 4.602 |
| September 11, 2026 | 4.653 |
| September 10, 2026 | 4.727 |
| September 09, 2026 | 4.702 |
| September 08, 2026 | 4.842 |
| September 04, 2026 | 4.978 |
| September 03, 2026 | 4.986 |
| September 02, 2026 | 4.942 |
| Date | Value |
|---|---|
| September 01, 2026 | 4.956 |
| August 31, 2026 | 4.998 |
| August 28, 2026 | 5.178 |
| August 27, 2026 | 5.577 |
| August 26, 2026 | 5.140 |
| August 25, 2026 | 5.088 |
| August 24, 2026 | 5.021 |
| August 21, 2026 | 5.144 |
| August 20, 2026 | 4.63 |
| August 19, 2026 | 4.765 |
| August 18, 2026 | 4.750 |
| August 17, 2026 | 4.677 |
| August 14, 2026 | 4.974 |
| August 13, 2026 | 4.911 |
| August 12, 2026 | 4.775 |
| August 11, 2026 | 4.694 |
| August 10, 2026 | 4.468 |
| August 07, 2026 | 4.286 |
| August 06, 2026 | 4.174 |
| August 05, 2026 | 4.209 |
| August 04, 2026 | 4.142 |
| August 03, 2026 | 4.094 |
| July 31, 2026 | 4.159 |
| July 30, 2026 | 4.167 |
| July 29, 2026 | 4.009 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.00 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8728 |
| Fulcrum Therapeutics, Inc. | 0.9220 |
| Definium Therapeutics, Inc. | 4.999 |
Price to Book Value Related Metrics
| PS Ratio | 23.85 |
| PEG Ratio | -0.0823 |
| Price | 0.2797 |
| Earnings Yield | -29.17% |
| Market Cap | 28.65M |
| PEGY Ratio | -0.0823 |